Abstract Introduction Primary ciliary dyskinesia (PCD) is a rare inherited disease associated with impairment of mucociliary transport and, consequently, with a high incidence of chronic rhinosinusitis. For patients with chronic rhinosinusitis who remain symptomatic despite medical treatment, endoscopic sinus surgery is a safe and effective therapeutic option. However, to date, no studies have been found evaluating the effect of surgery on the quality of life associated with the effect on olfaction and nasal endoscopy findings of patients with primary ciliary dyskinesia and chronic rhinosinusitis. Objective To describe the effect of endoscopic sinus surgery on the quality of life, on olfaction, and on nasal endoscopy findings of adults with PCD and chronic rhinosinusitis. Methods Four patients who underwent endoscopic sinus surgery were included. The Sinonasal Outcome Test-22 (SNOT-22) score, the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire, and the Lund-Kennedy score were collected preoperatively and at 3 and 6 months postoperatively. The olfaction as assessed with the University of Pennsylvania Smell Identification Test (UPSIT), which was administered preoperatively and 3 months postoperatively. Results A total of 4 patients with a mean age of 39.3 years old (3 men and 1 woman) completed the study. All patients showed clinically significant improvement in the SNOT-22, NOSE, and Lund-Kennedy scores at 3 months postoperatively, and this improvement was sustained throughout the follow-up period. However, olfaction did not improve after surgery. Conclusion The endoscopic sinus surgery treatment of chronic rhinosinusitis in adults with PCD was associated with improvement in quality of life and endoscopic findings. However, no improvement in olfaction was demonstrated. Studies with a larger number of patients and control groups should help confirm these findings. (PCD consequently option However date included Test22 22 Test-2 SNOT22 SNOT (SNOT-22 NOSE (NOSE questionnaire LundKennedy Lund Kennedy postoperatively UPSIT, UPSIT , (UPSIT) 393 39 39. ( woman study SNOT22, 22, SNOT-22 followup follow up period demonstrated Test2 2 Test- SNOT2 (SNOT-2 (UPSIT SNOT-2 (SNOT- SNOT- (SNOT

OBJETIVO: Estudar em pacientes submetidos à cirurgia de revascularização miocárdica com circulação extracorpórea os efeitos da infusão de azul de metileno na reação inflamatória sistêmica e nas condições hemodinâmica e laboratorial. MÉTODO: Foram estudados 60 pacientes randomizados em dois grupos, utilizando-se a infusão de azul de metileno em um dos dois grupos. Amostras de sangue foram colhidas antes da indução anestésica, 3, 6, 24 e 48 horas após o término da circulação extracorpórea para dosagens dos marcadores de inflamação (IL-1b, IL-6, IL-8, IL-10, IL-12p40 e TNFa), NO, gasometria e outras dosagens de rotina. RESULTADOS: O grupo que utilizou azul de metileno mostrou, em diferentes momentos das coletas, maior resistência vascular sistêmica, menor concentração de TNFa, menor número de leucócitos e neutrófilos e menor nível de óxido nítrico. Não ocorreram efeitos adversos importantes. CONCLUSÕES: A infusão de azul de metileno não evidenciou alterações clínicas ou pulmonares adversas, mostrando uma tendência menor à resposta inflamatória sistêmica, menores níveis de óxido nítrico e melhor estabilidade hemodinâmica.

OBJECTIVE: To assess the effects of methylene blue infusion on on-pump coronary artery bypass patients in relation to hemodynamic, laboratorial and systemic inflammatory response. METHOD: Sixty patients were randomized in two groups. Methylene blue was infused in one group. Blood samples were collected before the anesthesia and, 3, 6, 24 and 48 hours after the end of the extracoporeal circulation to determine the IL-1b, IL-6, IL-8, IL-10, IL-12p40, TNFa and nitric oxide levels and perform gasometry and other routine tests. RESULTS: In the methylene group we observed at different stages, higher systemic vascular resistance, lower TNFa concentrations, fewer leukocytes and neutrophils as well as lower level of nitric oxide. No adverse effects were evidenced. CONCLUSIONS: Methylene blue infusion showed less tendency of systemic inflammatory responses, lower levels of nitric oxide and a better hemodynamic performance.